Ranolazine 63304-0017-05
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 28, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA211707
Need to source Ranolazine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ranolazine | 500 mg/1 |
Drug Class
Anti-anginal [EPC]Anti-anginal [EPC]Cytochrome P450 2D6 Inhibitors [MoA]
Selected Package
63304-0017-05Selected500 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-017-05)
Other packages for this product(2)
180 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-017-28)
60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-017-60)